Expert Discusses Durvalumab and Future of Immunotherapy in NSCLC

Press/Media: Press / Media

PeriodOct 28 2018

Media coverage

1

Media coverage

  • TitleExpert Discusses Durvalumab and Future of Immunotherapy in NSCLC
    Media name/outletOncLive
    CountryUnited States
    Date10/28/18
    PersonsNeil Morganstein